150 related articles for article (PubMed ID: 7190964)
1. Microbial transformations of natural antitumor agents. 13. Conversions of 13-blocked anthracyclinones.
Wu GS; Gard A; Rosazza JP
J Antibiot (Tokyo); 1980 Jul; 33(7):705-10. PubMed ID: 7190964
[TBL] [Abstract][Full Text] [Related]
2. Microbial conversion of epsilon-pyrromycinone to 1-hydroxy-11-deoxycarminomycin II.
Nakagawa M; Hayakawa Y; Imamura K; Seto H; Otake N
J Antibiot (Tokyo); 1985 Jun; 38(6):821-2. PubMed ID: 4019326
[No Abstract] [Full Text] [Related]
3. Anthracycline antibiotic pharmacology and metabolism.
Bachur NR
Cancer Treat Rep; 1979 May; 63(5):817-20. PubMed ID: 455323
[TBL] [Abstract][Full Text] [Related]
4. Production of new anthracycline antibiotics 1-hydroxy-oxaunomycin and 6-deoxyoxaunomycin by limited biosynthetic conversion using a daunorubicin-negative mutant.
Yoshimoto A; Johdo O; Tone H; Okamoto R; Naganawa H; Sawa T; Takeuchi T
J Antibiot (Tokyo); 1992 Oct; 45(10):1609-17. PubMed ID: 1473988
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of 2'-deoxy-L-fucopyranosylcarminomycinone and -epsilon-pyrromycinone as well as 2'-deoxy-D-erythro-pentopyranosyldaunomycinone, -carminomycinone, and -epsilon-pyrromycinone.
El Khadem HS; Swartz DL
J Med Chem; 1981 Jan; 24(1):112-5. PubMed ID: 7205866
[TBL] [Abstract][Full Text] [Related]
6. Letter: Total synthesis of (+/-)-daunomycinone and (+/-)-carminomycinone.
Kende AS; Tsay YG; Mills JE
J Am Chem Soc; 1976 Mar; 98(7):1967-9. PubMed ID: 1254856
[No Abstract] [Full Text] [Related]
7. Microbial conversion of anthracyclinones to daunomycin by blocked mutants of Streptomyces coeruleorubidus.
Yoshimoto A; Oki T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1980 Oct; 33(10):1158-66. PubMed ID: 7451367
[TBL] [Abstract][Full Text] [Related]
8. Microbial conversion of anthracyclinones to carminomycins by a blocked mutant of Actinomadura roseoviolacea.
Nakagawa M; Hayakawa Y; Imamura K; Seto H; Otake N
J Antibiot (Tokyo); 1989 Nov; 42(11):1698-703. PubMed ID: 2584152
[TBL] [Abstract][Full Text] [Related]
9. Preparation and biological evaluation of 4-O-demethyldaunorubicin (carminomycin I) and of its 13-dihydro derivative.
Cassinelli G; Grein A; Masi P; Suarato A; Bernardi L; Arcamone F; Di Marco A; Casazza AM; Pratesi G; Soranzo C
J Antibiot (Tokyo); 1978 Mar; 31(3):178-84. PubMed ID: 649513
[TBL] [Abstract][Full Text] [Related]
10. A new antitumor antibiotic, carminomycin (NSC-180024).
Gause GF; Brazhnikova MG; Shorin VA
Cancer Chemother Rep; 1974; 58(2):255-6. PubMed ID: 4830498
[No Abstract] [Full Text] [Related]
11. Microbial transformation of rubeomycin A to rubeomycin B.
Ogawa Y; Mizukoshi S; Mori H
J Antibiot (Tokyo); 1983 Nov; 36(11):1561-3. PubMed ID: 6686224
[No Abstract] [Full Text] [Related]
12. Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. I. Glycosidation of various anthracyclinones by an aclacinomycin-negative mutant and biosynthesis of aclacinomycins from aklavinone.
Oki T; Yoshimoto A; Matsuzawa Y; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1980 Nov; 33(11):1331-40. PubMed ID: 6941952
[TBL] [Abstract][Full Text] [Related]
13. Microbial transformation of semisynthetic derivatives of daunomycinone modified in ring A.
Prikrylova V; Jizba J; Blumauerova M; Huk J; Sedmera P
Folia Microbiol (Praha); 1989; 34(5):459-62. PubMed ID: 2630409
[TBL] [Abstract][Full Text] [Related]
14. A new anthracycline metabolite D788-1 (10-carboxy-13-deoxocarminomycin) in daunorubicin beer.
Fujii S; Kubo K; Johdo O; Yoshimoto A; Ishikura T; Naganawa H; Sawa T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1986 Mar; 39(3):473-5. PubMed ID: 3700249
[No Abstract] [Full Text] [Related]
15. The anthracycline antineoplastic drugs.
Young RC; Ozols RF; Myers CE
N Engl J Med; 1981 Jul; 305(3):139-53. PubMed ID: 7017406
[No Abstract] [Full Text] [Related]
16. Chemical modification of anthracycline antibiotics IV. Synthesis of new anthracyclines with trisaccharide.
Tanaka H; Yoshioka T; Shimauchi Y; Matsushita Y; Matsuzawa Y; Oki T; Ishikura T
J Antibiot (Tokyo); 1982 Mar; 35(3):312-20. PubMed ID: 6951827
[TBL] [Abstract][Full Text] [Related]
17. 3'-deamino-3'-morpholino derivatives of daunomycin, adriamycin and carminomycin.
Takahashi Y; Kinoshita M; Masuda T; Tatsuta K; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1982 Jan; 35(1):117-8. PubMed ID: 7068512
[No Abstract] [Full Text] [Related]
18. Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
Young CW; Raymond V
Cancer Treat Rep; 1986 Jan; 70(1):51-63. PubMed ID: 2935251
[No Abstract] [Full Text] [Related]
19. A new anthracycline antibiotic SN-706.
Kimura K; Koyama T; Nakayama S; Tamura K; Miyata N; Kawanishi G
J Antibiot (Tokyo); 1988 Dec; 41(12):1918-21. PubMed ID: 3209485
[No Abstract] [Full Text] [Related]
20. Biosynthesis of anthracyclinones.
Eckardt K; Wagner C
J Basic Microbiol; 1988; 28(1-2):137-44. PubMed ID: 3171921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
